A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning

Bone Marrow Transplant. 2019 Jan;54(1):168-172. doi: 10.1038/s41409-018-0271-9. Epub 2018 Jun 29.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Allografts
  • Busulfan / administration & dosage*
  • Child
  • Child, Preschool
  • Granulomatous Disease, Chronic* / mortality
  • Granulomatous Disease, Chronic* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Prospective Studies
  • Transplantation Conditioning*
  • Unrelated Donors*

Substances

  • Busulfan